These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 23684315)
61. Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice. Engstrom AK; Snyder JM; Maeda N; Xia Z Mol Neurodegener; 2017 Feb; 12(1):14. PubMed ID: 28173832 [TBL] [Abstract][Full Text] [Related]
62. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674 [TBL] [Abstract][Full Text] [Related]
63. In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons. Najm R; Zalocusky KA; Zilberter M; Yoon SY; Hao Y; Koutsodendris N; Nelson M; Rao A; Taubes A; Jones EA; Huang Y Cell Rep; 2020 Jul; 32(4):107962. PubMed ID: 32726626 [TBL] [Abstract][Full Text] [Related]
65. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL; Tung YC; Liu F; Gong CX; Iqbal K Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379 [TBL] [Abstract][Full Text] [Related]
66. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. Leung L; Andrews-Zwilling Y; Yoon SY; Jain S; Ring K; Dai J; Wang MM; Tong L; Walker D; Huang Y PLoS One; 2012; 7(12):e53569. PubMed ID: 23300939 [TBL] [Abstract][Full Text] [Related]
68. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease. Reddy PH; Oliver DM Cells; 2019 May; 8(5):. PubMed ID: 31121890 [TBL] [Abstract][Full Text] [Related]
69. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. Huang Y Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952 [TBL] [Abstract][Full Text] [Related]
70. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice. Chan ES; Chen C; Cole GM; Wong BS Sci Rep; 2015 Sep; 5():13842. PubMed ID: 26346625 [TBL] [Abstract][Full Text] [Related]
71. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
72. The effects of the apoE4 genotype on the developing mouse retina. Maharshak I; Salomon-Zimri S; Antes R; Liraz O; Nisgav Y; Livnat T; Weinberger D; Colton CA; Solomon AS; Michaelson DM Exp Eye Res; 2016 Apr; 145():17-25. PubMed ID: 26554939 [TBL] [Abstract][Full Text] [Related]
73. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways. Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057 [TBL] [Abstract][Full Text] [Related]
74. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. Krantic S; Isorce N; Mechawar N; Davoli MA; Vignault E; Albuquerque M; Chabot JG; Moyse E; Chauvin JP; Aubert I; McLaurin J; Quirion R J Alzheimers Dis; 2012; 29(2):293-308. PubMed ID: 22232004 [TBL] [Abstract][Full Text] [Related]
75. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease. Zhu C; Xu B; Sun X; Zhu Q; Sui Y Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757 [TBL] [Abstract][Full Text] [Related]
76. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470 [TBL] [Abstract][Full Text] [Related]
77. Active full-length DNA Aβ Rosenberg RN; Fu M; Lambracht-Washington D Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039 [TBL] [Abstract][Full Text] [Related]
78. Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice. Van Dooren T; Muyllaert D; Borghgraef P; Cresens A; Devijver H; Van der Auwera I; Wera S; Dewachter I; Van Leuven F Am J Pathol; 2006 Jan; 168(1):245-60. PubMed ID: 16400027 [TBL] [Abstract][Full Text] [Related]
79. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles. Qin X; Wang Y; Paudel HK Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077 [TBL] [Abstract][Full Text] [Related]